432 related articles for article (PubMed ID: 34360751)
1. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.
Rochette L; Ghibu S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360751
[TBL] [Abstract][Full Text] [Related]
2. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
[TBL] [Abstract][Full Text] [Related]
3. "When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review.
Kounis NG; Gogos C; de Gregorio C; Hung MY; Kounis SN; Tsounis EP; Assimakopoulos SF; Pourmasumi S; Mplani V; Servos G; Dousdampanis P; Plotas P; Michalaki MA; Tsigkas G; Grammatikopoulos G; Velissaris D; Koniar I
Balkan Med J; 2024 Jan; 41(1):7-22. PubMed ID: 38173173
[TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.
Youn JY; Zhang Y; Wu Y; Cannesson M; Cai H
Redox Biol; 2021 Oct; 46():102099. PubMed ID: 34509916
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and L-arginine Supplementations: Yet to Find the Missed Key.
Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Batiha GE
Curr Protein Pept Sci; 2022; 23(3):166-169. PubMed ID: 35549865
[TBL] [Abstract][Full Text] [Related]
7. Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.
Cure E; Cumhur Cure M
Med Hypotheses; 2020 Oct; 143():110185. PubMed ID: 33017914
[TBL] [Abstract][Full Text] [Related]
8. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
Ramasamy S; Subbian S
Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
[TBL] [Abstract][Full Text] [Related]
9. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
Amraei R; Rahimi N
Cells; 2020 Jul; 9(7):. PubMed ID: 32660065
[TBL] [Abstract][Full Text] [Related]
10. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
11. Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.
Cooper SL; Boyle E; Jefferson SR; Heslop CRA; Mohan P; Mohanraj GGJ; Sidow HA; Tan RCP; Hill SJ; Woolard J
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361021
[TBL] [Abstract][Full Text] [Related]
12. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
Albini A; Di Guardo G; Noonan DM; Lombardo M
Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
Gan R; Rosoman NP; Henshaw DJE; Noble EP; Georgius P; Sommerfeld N
Med Hypotheses; 2020 Nov; 144():110024. PubMed ID: 32758871
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
Bhargavan B; Kanmogne GD
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
[TBL] [Abstract][Full Text] [Related]
17. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.
Maiuolo J; Mollace R; Gliozzi M; Musolino V; Carresi C; Paone S; Scicchitano M; Macrì R; Nucera S; Bosco F; Scarano F; Zito MC; Ruga S; Tavernese A; Mollace V
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291346
[TBL] [Abstract][Full Text] [Related]
18. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
Bernard I; Limonta D; Mahal LK; Hobman TC
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
Norooznezhad AH; Mansouri K
Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]